KR101948944B1 - 혈액 성분을 포함하는 피브리노겐-함유 샘플로부터 표적 분자 또는 입자를 분리하는 방법 - Google Patents

혈액 성분을 포함하는 피브리노겐-함유 샘플로부터 표적 분자 또는 입자를 분리하는 방법 Download PDF

Info

Publication number
KR101948944B1
KR101948944B1 KR1020137009329A KR20137009329A KR101948944B1 KR 101948944 B1 KR101948944 B1 KR 101948944B1 KR 1020137009329 A KR1020137009329 A KR 1020137009329A KR 20137009329 A KR20137009329 A KR 20137009329A KR 101948944 B1 KR101948944 B1 KR 101948944B1
Authority
KR
South Korea
Prior art keywords
sample
fibrinogen
fibrin
delete delete
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020137009329A
Other languages
English (en)
Korean (ko)
Other versions
KR20130107300A (ko
Inventor
아마르 리다
니콜라스 메르모드
파트리스 프랑스와
블라디미르 라자레빅
자크 슈렌젤
Original Assignee
데비오팜 인터네셔날 에스 에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데비오팜 인터네셔날 에스 에이 filed Critical 데비오팜 인터네셔날 에스 에이
Publication of KR20130107300A publication Critical patent/KR20130107300A/ko
Application granted granted Critical
Publication of KR101948944B1 publication Critical patent/KR101948944B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/14—Streptococcus; Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Sampling And Sample Adjustment (AREA)
KR1020137009329A 2010-09-15 2011-09-15 혈액 성분을 포함하는 피브리노겐-함유 샘플로부터 표적 분자 또는 입자를 분리하는 방법 Active KR101948944B1 (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CH01478/10 2010-09-15
CH14782010 2010-09-15
CH20412010 2010-12-07
CH02041/10 2010-12-07
CH01207/11 2011-07-20
CH12072011 2011-07-20
PCT/IB2011/054035 WO2012035508A2 (en) 2010-09-15 2011-09-15 Method for separating target molecules or particles from fibrinogen-containing samples including blood components

Publications (2)

Publication Number Publication Date
KR20130107300A KR20130107300A (ko) 2013-10-01
KR101948944B1 true KR101948944B1 (ko) 2019-02-15

Family

ID=45044632

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137009329A Active KR101948944B1 (ko) 2010-09-15 2011-09-15 혈액 성분을 포함하는 피브리노겐-함유 샘플로부터 표적 분자 또는 입자를 분리하는 방법

Country Status (17)

Country Link
US (4) US9689881B2 (enExample)
EP (2) EP2616550B1 (enExample)
JP (1) JP5999776B2 (enExample)
KR (1) KR101948944B1 (enExample)
CN (2) CN107389932B (enExample)
AU (2) AU2011303467C1 (enExample)
CA (1) CA2811493C (enExample)
CY (1) CY1122166T1 (enExample)
DK (2) DK2616550T3 (enExample)
ES (2) ES2751660T3 (enExample)
HR (1) HRP20191785T1 (enExample)
HU (2) HUE028915T2 (enExample)
LT (1) LT3067431T (enExample)
PL (2) PL2616550T3 (enExample)
PT (1) PT3067431T (enExample)
SI (1) SI3067431T1 (enExample)
WO (1) WO2012035508A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9689881B2 (en) 2010-09-15 2017-06-27 Spinomix S.A. Method for separating target molecules or particles from fibrinogen-containing samples including blood components
CN103702674B (zh) 2011-06-27 2018-05-29 爱默蕾大学 血小板裂解物的组合物、用途和制备
EP2979093B1 (en) * 2013-03-29 2019-10-23 Siemens Healthcare Diagnostics Inc. Rare cell concentration
ES2740838T3 (es) * 2014-06-01 2020-02-06 Debiopharm Int Sa Dispositivo de recolección y procesamiento de muestras
US12397302B2 (en) 2015-11-30 2025-08-26 Dh Technologies Development Pte. Ltd. Electromagnetic assemblies for processing fluids
WO2017156375A1 (en) 2016-03-10 2017-09-14 Arthrex, Inc. Systems and methods for preparing a thrombin serum
WO2017156379A2 (en) 2016-03-10 2017-09-14 Arthrex, Inc. Systems and methods for preparing protein enhanced serums
KR20210052389A (ko) 2018-08-27 2021-05-10 리제너론 파마슈티칼스 인코포레이티드 다운스트림 정제에서의 라만 분광법의 사용
JP7298449B2 (ja) * 2019-11-14 2023-06-27 株式会社島津製作所 血液凝固分析装置、及び分注ノズルの洗浄方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030068662A1 (en) * 1987-12-24 2003-04-10 Institut Pasteur Reagent for the detection of Staphylococcus aureus by agglutination
WO2005021799A2 (en) * 2003-08-15 2005-03-10 University Of South Florida Materials and methods for capture of pathogens and removal of aurintricarboxylic acid from a sample
JP2009052166A (ja) * 2007-08-27 2009-03-12 Toray Ind Inc シート状物の製造方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1035260A (en) * 1974-08-12 1978-07-25 Baxter Travenol Laboratories Collection and processing tube
DE58902472D1 (de) * 1988-01-05 1992-11-26 Linhart Axel Verfahren und test-kit zur semiquantitativen bestimmung des kalziumgehaltes im blut.
DE3803463A1 (de) * 1988-02-05 1989-08-17 Linhart Axel Semiquantitativer kalzium-schnelltest
US5691160A (en) * 1992-08-14 1997-11-25 Biogen, Inc. Effects of actin filaments of fibrin clot structure and lysis
EP0587398B1 (en) * 1992-09-09 1998-01-14 Tokuyama Corporation Method of assaying fibrinogen, dry reagent therefor, and process for the preparation thereof
JP3292760B2 (ja) * 1993-04-22 2002-06-17 テルモ株式会社 採血管およびその製造方法
US5670329A (en) * 1993-05-28 1997-09-23 Cardiovascular Diagnostics, Inc. Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field
WO1995015397A1 (en) 1993-12-03 1995-06-08 Dorn Gordon L Method for improving quantitative recovery of microorganisms fro m specimens containing blood components
DE19602673A1 (de) * 1996-01-25 1997-08-07 Pereg Gmbh Synthetische Testanschmutzung
US6121232A (en) * 1997-01-31 2000-09-19 Omrix Biopharmaceuticals Sa Stabilized mixture comprising fibrinogen
US6680195B1 (en) * 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
JP2000262499A (ja) * 2000-01-01 2000-09-26 Terumo Corp 採血管
US6686204B2 (en) * 2001-08-27 2004-02-03 Becton, Dickinson & Company Collection device
WO2003028743A1 (en) * 2001-10-03 2003-04-10 Woolverton Christopher J Storage-stable fibrinogen solutions
JP4718833B2 (ja) * 2002-05-01 2011-07-06 シナプス ベスローテン フェンノートシャップ 複合生物媒体における、一時的なタンパク質分解活性の濃度を決定するための診断試験
EP1400589B1 (de) 2002-09-18 2006-08-09 SIRS-Lab GmbH Verfahren zum Nachweis prokaryontischer DNA
US20050065454A1 (en) * 2003-09-22 2005-03-24 Becton, Dickinson And Company Non-evacuated blood collection tube
US7399609B2 (en) * 2003-12-30 2008-07-15 3M Innovative Properties Company Staphylococcus detection
US8419722B2 (en) * 2004-10-29 2013-04-16 Spinal Restoration, Inc. Apparatus and method for injection of fibrin sealant in spinal applications
DE102005009479A1 (de) 2005-03-02 2006-09-07 Molzym Gmbh & Co. Kg Verwendung von Nukleasen zum Abbau von Nukleinsäure in Gegenwart von chaotropen Agenzien und/oder Tensiden
US20100009409A1 (en) * 2005-07-29 2010-01-14 Ecole Polytechnique Federale De Lausanne Molecular variant fibrinogen fusion proteins
US20080299587A1 (en) * 2007-05-03 2008-12-04 Dennis Durbin Methods of measuring inhibition of platelet aggregation by thrombin receptor antagonists
CA2693565C (en) 2007-08-02 2015-05-26 Universite Laval Concentration and enrichment of microbial cells and microbial nucleic acids from bodily fluids
ES2585246T3 (es) * 2008-07-09 2016-10-04 Profibrix Bv Fibrinógeno recombinante
CA2768485C (en) 2009-07-16 2018-12-04 Timothy Foster Treatment of staphylococci infections using recombinant fibrinogen binding protein clumping factor a
US9689881B2 (en) 2010-09-15 2017-06-27 Spinomix S.A. Method for separating target molecules or particles from fibrinogen-containing samples including blood components

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030068662A1 (en) * 1987-12-24 2003-04-10 Institut Pasteur Reagent for the detection of Staphylococcus aureus by agglutination
WO2005021799A2 (en) * 2003-08-15 2005-03-10 University Of South Florida Materials and methods for capture of pathogens and removal of aurintricarboxylic acid from a sample
JP2009052166A (ja) * 2007-08-27 2009-03-12 Toray Ind Inc シート状物の製造方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Journal of Thrombosis and Haemostasis, Vol. 2, pp. 561-573 (2004.)

Also Published As

Publication number Publication date
KR20130107300A (ko) 2013-10-01
US20210148940A1 (en) 2021-05-20
AU2011303467B2 (en) 2016-09-15
US20130164737A1 (en) 2013-06-27
CA2811493A1 (en) 2012-03-22
JP5999776B2 (ja) 2016-09-28
AU2011303467C1 (en) 2017-03-09
EP3067431A1 (en) 2016-09-14
EP2616550A2 (en) 2013-07-24
WO2012035508A3 (en) 2012-05-18
PT3067431T (pt) 2019-10-29
ES2571127T3 (es) 2016-05-24
WO2012035508A2 (en) 2012-03-22
EP2616550B1 (en) 2016-02-10
CN103108959A (zh) 2013-05-15
HRP20191785T1 (hr) 2019-12-27
HUE028915T2 (en) 2017-01-30
JP2013538355A (ja) 2013-10-10
AU2016266066A1 (en) 2016-12-22
PL2616550T3 (pl) 2016-08-31
SI3067431T1 (sl) 2019-11-29
HK1247280A1 (zh) 2018-09-21
DK3067431T3 (da) 2019-10-14
CN107389932B (zh) 2019-11-22
WO2012035508A4 (en) 2012-07-19
AU2016266066B2 (en) 2017-12-21
EP3067431B1 (en) 2019-07-24
HUE045771T2 (hu) 2020-01-28
US20170336424A1 (en) 2017-11-23
US9689881B2 (en) 2017-06-27
CA2811493C (en) 2020-06-16
CY1122166T1 (el) 2020-11-25
PL3067431T3 (pl) 2019-12-31
DK2616550T3 (en) 2016-05-23
ES2751660T3 (es) 2020-04-01
AU2011303467A1 (en) 2013-04-04
US20240280593A1 (en) 2024-08-22
CN107389932A (zh) 2017-11-24
CN103108959B (zh) 2017-06-09
LT3067431T (lt) 2019-11-11

Similar Documents

Publication Publication Date Title
KR101948944B1 (ko) 혈액 성분을 포함하는 피브리노겐-함유 샘플로부터 표적 분자 또는 입자를 분리하는 방법
US8785176B2 (en) Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA
HK1247280B (zh) 用於从含纤维蛋白原的样品中分离目标分子或颗粒的方法
AU2012216623B2 (en) Materials and methods for capture of pathogens and removal of aurintricarboxylic acid from a sample
AU2013203143B2 (en) Materials and methods for capture of pathogens and removal of aurintricarboxylic acid from a sample
Amuso Post protein hydrolysis removal ofa potent ribonuclease inhibitor and the enzymatic capture of

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20130412

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20150729

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20160907

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20171030

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20180921

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20171030

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20180921

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20180430

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20160907

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20181113

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20181029

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20180921

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20180430

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20160907

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20190211

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20190211

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20220127

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20240124

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20250122

Start annual number: 7

End annual number: 7